The aim of the present study was to investigate the potential role of two markers, Suppression of tumorigenicity 2 (ST2) and Regenerating islet-derived protein 3 alpha (Reg3a), in the prediction of acute GVHD. The gene discussed is REG3A; the disease is acute graft versus host disease.